Order Article Reprints

Jin H, Lu W, Zhang Y, Wu Y, Ding J, Orion IRCV, Liu C. Functionalized Periodic Mesoporous Silica Nanoparticles for Inhibiting the Progression of Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol. Pharmaceutics. 2024; 16(1):74. https://doi.org/10.3390/pharmaceutics16010074

Jin, Hao, Wenbin Lu, Yahao Zhang, Yong Wu, Jiandong Ding, I. R. Chiara Villamil Orion, and Cihui Liu. 2024. "Functionalized Periodic Mesoporous Silica Nanoparticles for Inhibiting the Progression of Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol" Pharmaceutics 16, no. 1: 74. https://doi.org/10.3390/pharmaceutics16010074

Jin, H., Lu, W., Zhang, Y., Wu, Y., Ding, J., Orion, I. R. C. V., & Liu, C. (2024). Functionalized Periodic Mesoporous Silica Nanoparticles for Inhibiting the Progression of Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol. Pharmaceutics, 16(1), 74. https://doi.org/10.3390/pharmaceutics16010074